1Chaudary PM, Mechetner EB, Roninson IB. Expression and activity of the multidrug resistance P-glycoprotein in human peripheial blood lymphocytes [J]. Blood, 1992,80 ( 11 ) : 2 735-2739. 被引量：1
2Zori Comba A,Blajman C,Richardet E. A randomised phase Ⅱ study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic(Mayo Clinic regimen)in previously untreated colorectal cancer patients [J]. Eur J Cancer, 2001,37 ( 8 ) :1 006-1 013. 被引量：1
3Andre T,Louvet C, Roymond K. Bimonthly high-dose leucovorin,5-fluorouracil infusion and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen[J]. Ann Onco1,1998,9(11) :1 251-1 253. 被引量：1
4Schull B, Kornek GV, Schmid K. Second-line treatment of advanced colorectal cancer with a biweekly oxaliplatin plus irinotecan combination regimen[J]. Oncology,2002,25(4) :358-362. 被引量：1
6Dalton WS. Clinical and laboratory approaches to drug resistance(review) [J]. Curt Opin Oncol, 1991,3(6) : 1 043-1 048. 被引量：1
7Solary E, Caillot D, Chauffert B. Feasibility of using quinine, a potential multidrug resistance-reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia [J].J Clin Onco1,1992,10(11):1 730-1 736. 被引量：1
8Trump DL, Smith 13(2, Ellis PG. , et al. High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent:phase I trial in combination with vinblastine [J]. J Natl Cancer Inst, 1992,84(23):1 811-1 816. 被引量：1
9Li J,Xu LZ, He KL,et al. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer line [J]. Breast Cancer Res,2001,3(4):253~263. 被引量：1
10Neuhoff S,Langguth P,Dressler C,et al. Affinities at the verapamil binding site of MDRl-encoded P-glycoprotent: drugs and analogs, stereo isomers and metabolites [J]. Int J Clin Pharmacol Ther,2000,38(4) : 168- 179. 被引量：1
